Tag: Schizophrenia
J&J buys Intra-Cellular in $14.6B deal, delving into central nervous system disorders
Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular...
A promising schizophrenia drug showed mixed results. What does that mean for patients?
Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of...